Insider filing · ARWR
Patrick O'Brien
COO and General Counsel
profile →
Arrowhead Pharmaceuticals, Inc.
ARWR · Healthcare · 34 filings in 24 months
ticker →
Patrick O'Brien sold $2.9M of Arrowhead Pharmaceuticals (ARWR)
Executed Jan 5, disclosed Jan 5, the same day.
Value, as filed
$2.9M
46,734 sh across 7 lots
Executed
Jan 5
the trade date, as filed
Disclosed
Jan 5
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
PBPatrick O'Brien (COO and General Counsel) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Arrowhead Pharmaceuticals, Inc. (ARWR). The largest single filing was $2.9M of ARWR (46,734 sh across 7 lots, as filed), executed Jan 5.
The name
ARWRHealthcare · Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Patrick O'Brien in ARWR
ARWRSALE
Arrowhead Pharmaceuticals, Inc.
$736K37,184 sh across 3 lots
Exec Jan 6 2025
Filed Jan 7 2025 · 5:30 PM ET